Shawnbir Gogia, MD
Interventional Cardiology · Los Angeles, CANPI 1467834697
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $27,311 of the $43,944 with a category attached, or 62.2%. 24 manufacturers reported payments, led by Boston Scientific at 36.8% of the total. Reporting peaked in 2021 at $14,452 and has fallen 58.1% since, to $6,051 in 2025.
Across 555 payments — averaging $79.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$16K
- Edwards Lifesciences$9K
- Abiomed$6K
- Abbott$4K
- Medtronic$3K
- Shockwave Medical, Inc$1K
- plus $4K from 18 others
What the payments were for
- Grants$12,62529%
- Travel & lodging$3,0227%
- Food & beverage$27,31162%
- Education$9852%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 54 | $16,151 |
| Edwards Lifesciences | 235 | $9,275 |
| Abiomed | 90 | $6,092 |
| Abbott | 84 | $4,488 |
| Medtronic | 25 | $2,876 |
| Shockwave Medical, Inc | 10 | $1,424 |
| AstraZeneca | 13 | $992 |
| Cardiovascular Systems Inc. | 5 | $549 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $356 |
| Terumo Medical Corporation | 1 | $252 |
| Johnson & Johnson | 2 | $242 |
| Heartflow, Inc. | 3 | $211 |
| Astellas Pharma US Inc | 2 | $157 |
| Chiesi USA, Inc. | 3 | $154 |
| Philips North America LLC | 5 | $150 |
| Asahi Intecc USA, Inc. | 1 | $142 |
| Ancora Heart, Inc. | 4 | $130 |
| Angiodynamics, Inc. | 1 | $103 |
| W. L. Gore & Associates, Inc. | 2 | $73 |
| Boehringer Ingelheim | 2 | $36 |
| Kestra Medical Technology Services, Inc. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| B. Braun Interventional Systems Inc. | 1 | $23 |
| Cordis US CORP. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - STENTS$12,500
- Impella$2,077
- SAPIEN 3 Ultra RESILIA$1,828
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$1,406
- MitraClip$1,315
- COREVALVE EVOLUT R$1,222
- AVVIGO Guidance System$928
- BRILINTA$513
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$489
- Diamondback Coronary$465
- APOLLOTM$430
- Resolute$280
- Emerge Push$278
- Edwards SAPIEN 3 Transcatheter Heart Valve$277
- OPTIS$257
- AMPLATZER AMULET$243
- XARELTO$242
- DRAGONFLY OPSTAR$232
- EVOQUE$214
- CARDIOMEMS$210
How this compares
$43,944 in reported general payments places this provider in the 80th percentile of 585 interventional cardiology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 65 | $386 |
| Rosuvastatin Calcium | 12 | $359 |
| Carvedilol | 28 | $275 |
| ClopidogrelClopidogrel Bisulfate | 21 | $160 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 11 | $76 |
| Lisinopril | 26 | $69 |
| Amlodipine Besylate | 19 | $21 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Los Angeles
- Evan ZahnLos Angeles$632K
- Steven BursteinLos Angeles$352K
- Jubin JosephLos Angeles$217K
- Ali NsairLos Angeles$162K
- Ray MatthewsLos Angeles$159K
- Daniel AsemotaLos Angeles$155K
- Christina EconomidesLos Angeles$150K
- Aakriti GuptaLos Angeles$139K
- Matthew Pricela Jolla$2.3M
- Frederick St GoarMountain View$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.